CLOS
TARO

Compagnie Lombard Odier SCmA’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50
Closed -$6K – 872
2016
Q3 		$6K Hold
50
– – ﹤0.01% 865
2016
Q2 		$7K Sell
50
-50
-50% -$7.09K ﹤0.01% 853
2016
Q1 		$14K Buy
+100
New +$14.2K ﹤0.01% 860

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Compagnie Lombard Odier SCmA's TARO Position: Q4 2016 in Review

Compagnie Lombard Odier SCmA sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 50 shares — an estimated $6K sold.

Compagnie Lombard Odier SCmA first reported a position in TARO in Q1 2016 and held it in 3 quarters. The position peaked at $14K in Q1 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • Compagnie Lombard Odier SCmA reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 50 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $6K.
  • Compagnie Lombard Odier SCmA first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 3 quarters.
  • Compagnie Lombard Odier SCmA's Taro Pharmaceutical Industries Ltd. position peaked at $14K in Q1 2016.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2016, filed 14 Feb 2017.